Skip to main content
Back
Watch Compare

ENANTA PHARMACEUTICALS INC

Data quality: 100%
ENTA
Nasdaq Manufacturing Chemicals
$14.11
▲ $0.16 (1.15%)
Mkt Cap: 403.37 M
Price
$13.90
Mkt Cap
403.37 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue declined -9.43% annually over 5 years
Negative free cash flow of -44.01 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 6.01%

Growth

Revenue Growth (5Y)
-9.43%
Below sector avg (1.82%)
Revenue (1Y)-3.42%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-91.15%
Below sector avg (-53.47%)
ROIC-28.20%
Net Margin-111.78%
Op. Margin-115.09%

Safety

Debt / Equity
N/A
Current Ratio4.44
Interest Coverage-8.97

Valuation

PE (TTM)
-4.30
Below sector avg (-1.48)
P/B Ratio3.19
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -4.3 -1.5
P/B 3.2 1.6
ROE % -91.2 -53.5
Net Margin % -111.8 -41.5
Rev Growth 5Y % -9.4 1.8
D/E — 0.3

Analyst Price Target

6 analysts
Buy
Current
$14.11
+31.1%
Target
$18.50
$12.00
$20.00
$20.00
Forecast
Forward P/E -6.39
Forward EPS -$2.21
Est. Revenue 65.87 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$2.21
-$3.08 – -$1.60
 65.87 M 5
FY2026 -$2.13
-$2.55 – -$1.31
 66.40 M 4

Earnings Surprises

Last 5 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.88 -$0.42 +52.1%
Q32025 -$1.01 -$0.87 +13.9%
2026-Q1 -$0.51 -$0.42 +17.2%
Q22025 -$0.89 -$0.85 +4.0%
Q12025 -$1.14 -$1.06 +6.7%

ETFs Holding This Stock

SHISX SHISX
0.10% weight
SHSCX SHSCX
0.10% weight
SHSAX SHSAX
0.10% weight
BRSIX BRSIX
0.08% weight
GSATX GSATX
0.07% weight
GSCTX GSCTX
0.07% weight
GTTUX GTTUX
0.07% weight
GTTTX GTTTX
0.07% weight
GSXPX GSXPX
0.07% weight
GTTRX GTTRX
0.07% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -3.42% Revenue Growth (3Y) -9.18%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -9.43% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 83.94 M Net Income (TTM) -93.83 M
ROE -91.15% ROA -29.76%
Gross Margin N/A Operating Margin -115.09%
Net Margin -111.78% Free Cash Flow (TTM) -44.01 M
ROIC -28.20% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4.44
Interest Coverage -8.97 Asset Turnover 0.27
Working Capital 153.96 M Tangible Book Value 126.59 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.30 Forward P/E N/A
P/B Ratio 3.19 P/S Ratio 4.81
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -10.91%
Market Cap 403.37 M Enterprise Value 365.93 M
Per Share
EPS (Diluted TTM) -4.26 Revenue / Share 2.89
FCF / Share -1.52 OCF / Share -1.07
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 15.53% FCF Conversion 46.91%
SBC-Adj. FCF -67.77 M Growth Momentum 6.01

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 65.32 M 67.64 M 79.20 M 86.16 M 97.07 M
Net Income -81.89 M -116.05 M -133.82 M -121.76 M -79.00 M
EPS (Diluted) -3.84 -5.48 -6.38 -5.91 -3.92
Gross Profit — — — — —
Operating Income -85.35 M -121.69 M -137.21 M -123.84 M -109.57 M
EBITDA — — — — —
R&D Expenses 106.74 M 131.48 M 163.52 M 164.52 M 174.11 M
SG&A Expenses — — — — —
D&A 4.59 M 2.34 M 2.37 M 2.97 M 3.33 M
Interest Expense 7.68 M 10.94 M 5.15 M — —
Income Tax -1.66 M -1.74 M 2.82 M -433,000.0 -28.58 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 280.73 M 376.65 M 462.28 M 375.41 M 438.79 M
Total Liabilities 216.02 M 247.84 M 245.54 M 54.08 M 39.36 M
Shareholders' Equity 64.72 M 128.81 M 216.74 M 321.33 M 399.43 M
Total Debt — — — — —
Cash & Equivalents 32.30 M 37.23 M 85.39 M 43.99 M 57.21 M
Current Assets 204.34 M 299.85 M 422.79 M 311.71 M 319.02 M
Current Liabilities 48.56 M 57.54 M 62.79 M 29.83 M 36.17 M